These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3919398)

  • 61. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
    Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
    Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hyaluronic acid in human synovial effusions; a sensitive indicator of altered connective tissue cell function during inflammation.
    Castor CW; Prince RK; Hazelton MJ
    Arthritis Rheum; 1966 Dec; 9(6):783-94. PubMed ID: 5297217
    [No Abstract]   [Full Text] [Related]  

  • 63. Serum levels of alpha-interferon and gamma-interferon in patients with acute and chronic viral hepatitis.
    Kakumu S; Fuji A; Yoshioka K; Tahara H
    Hepatogastroenterology; 1989 Apr; 36(2):97-102. PubMed ID: 2499528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases.
    Treuhaft PS; MCCarty DJ
    Arthritis Rheum; 1971; 14(4):475-84. PubMed ID: 5564921
    [No Abstract]   [Full Text] [Related]  

  • 65. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases.
    Gabrijelcic D; Annan-Prah A; Rodic B; Rozman B; Cotic V; Turk V
    J Clin Chem Clin Biochem; 1990 Mar; 28(3):149-53. PubMed ID: 2329322
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor.
    Firestein GS; Zvaifler NJ
    Arthritis Rheum; 1987 Aug; 30(8):864-71. PubMed ID: 3115274
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An assay for estimating the cytotoxicity of synovial fluid from patients with rheumatoid arthritis.
    Blann AD
    Scand J Clin Lab Invest; 1985 Nov; 45(7):665-7. PubMed ID: 4070964
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Concentration of carprofen in the serum and the synovial fluid in rheumatoid arthritis patients.
    Jalava S; Heizmann P; Kylmämaa T
    Scand J Rheumatol Suppl; 1983; 48():11-2. PubMed ID: 6573017
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [AMINOTRIPEPTIDASE ACTIVITY IN SYNOVIAL FLUID. I].
    HUETTL S; MARKOVIC O
    Bratisl Lek Listy; 1963; 43():585-96. PubMed ID: 14061763
    [No Abstract]   [Full Text] [Related]  

  • 71. Synovial fluid analysis--another look at the mucin clot test.
    Hogan DB; Pritzker KP
    J Rheumatol; 1985 Apr; 12(2):242-4. PubMed ID: 3875719
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteins.
    Lu-Steffes M; Iammartino AJ; Schmid FR; Castor CW; Davis L; Entwistle R; Anderson B
    Ann Clin Lab Sci; 1982; 12(3):178-85. PubMed ID: 7092168
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum and synovial fluid inhibitors of antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.
    Arthritis Rheum; 1976; 19(2):142-9. PubMed ID: 56939
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antinuclear antibodies and nuclear antigens in rheumatoid synovial fluids.
    Robitaille P; Zvaifler NJ; Tan EM
    Clin Immunol Immunopathol; 1973 Apr; 1(3):385-97. PubMed ID: 4201401
    [No Abstract]   [Full Text] [Related]  

  • 75. Hydroxyproline levels and collagenolytic activity in synovial fluids of patients with rheumatic diseases.
    Wize J; Sopata I; Gietka J; Jakubowski S; Kruze D
    Scand J Rheumatol; 1975; 4(2):65-72. PubMed ID: 1135610
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The synovial fluid.
    Blau SP
    Orthop Clin North Am; 1979 Jan; 10(1):21-35. PubMed ID: 450398
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
    Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
    Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
    Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
    Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Immunologic study of synovial fluid. I. Investigation of the rheumatoid factor, intraleukocytic immunolobulins, antinuclear antibodies and anticonstitutents of the nucleus].
    Solnica J; Kahn MF; de Sèze S
    Rev Rhum Mal Osteoartic; 1968 Jun; 35(6):312-21. PubMed ID: 4178302
    [No Abstract]   [Full Text] [Related]  

  • 80. 5-Hydroxytryptamine metabolism in joint diseases.
    Igari T; Toba Y; Obara K; Ono S
    Tohoku J Exp Med; 1974 Apr; 112(4):355-9. PubMed ID: 4855452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.